Stein-Gold, L, B Elewski, Z Draelos, and T Lin. “Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 4, no. 1 (January 28, 2020): S9. Accessed June 30, 2022. https://www.jofskin.org/index.php/skin/article/view/822.